Clinical Trial Update: Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan [Phase 1, Phase 2]

View source ↗

Summary

Completion of Phase 1/Phase 2 evaluation of a candidate Clostridioides difficile toxoid vaccine in healthy adults aged 40-75 years in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Clostridioides difficile toxoid vaccine (candidate)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Clostridium Difficile Infection | Phase 1, Phase 2 | Status: COMPLETED